optimizing frontline treatment for ptcl: introducing novel agents into chop-based regimens
Published 1 month ago • 71 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
1:39
insights into the main subtypes of ptcl
-
2:03
5-year follow-up of echelon-2: a chp vs chop for cd30 ptcl
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
0:56
fixed-duration treatment strategies for frontline and relapsed cll
-
1:59
a strategy for curing cll, one clone at a time
-
31:19
hcp roundtable: fine-tuning cll dose modification and side effect management strategies
-
14:21
point of care testing: quality and implementation
-
54:48
improving prep hplc
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
3:45
from project starter kits to yaml highlighting: discover what's new in helpndoc 8.9
-
0:55
up.sight™: the ultimate upgrade in cell line development
-
3:28
the implementation of a data-driven cll-tim algorithm into an epic-based electronic health record
-
7:28
covid-19: impact on treating and diagnosing all
-
9:13
brightcove vs teyuto | the future of vod (video on demand)
-
2:30
releasing time to care enabled by technology
-
1:40
optim 1 professional disinfection wipes 2023
-
0:22
ensuring quality in every step of your journey in cincinnati, ohio
-
57:30
essentials of writing a protocol for a systematic review
-
10:01
8) home page
-
2:05
part 5 - concluding remarks and take-home points
-
3:03
monday minutes novelist select in koha